(±)-CP 47497

Discontinued Product

(±)-CP 47497 (Cat. No. 3500) has been withdrawn from sale for commercial reasons.
Cat.No. 3500 - (±)-CP 47497 | C21H34O2 | CAS No. 70434-82-1
Description: Potent CB1 agonist
Chemical Name: rel-5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]phenol
Purity: ≥98% (HPLC)

Biological Activity

Potent CB1 receptor agonist (Ki = 2.2 nM). Exhibits analgesic, motor depressant, anticonvulsant and hypothermic effects in vivo.

Technical Data

M. Wt 318.49
Formula C21H34O2
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 70434-82-1
PubChem ID 90488849
Smiles CC(CCCCCC)(C)C(C=C2O)=CC=[C@@]2[C@H]1CCC[C@@H](O)C1.CC(CCCCCC)(C)C(C=C4O)=CC=[C@@]4[C@@H]3CCC[C@H](O)C3

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets

Certificate of Analysis / Product Datasheet
Select another batch:


References are publications that support the biological activity of the product.

Weissman et al (1982) Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol. J.Pharmacol.Exp.Ther. 223 516 PMID: 6290642

Melvin et al (1993) Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs. Mol.Pharmacol. 44 1008 PMID: 8246904

Huffman et al (2008) Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940. Bioorg.Med.Chem. 16 322 PMID: 17919913

View Related Products by Target

View Related Products by Product Action

View all CB1 Receptor Agonists

Keywords: (±)-CP 47497, (±)-CP 47497 supplier, Potent, CB1, agonists, cannabinoids, Receptors, (±)-CP47497, cb1r, 3500, Tocris Bioscience

Citations for (±)-CP 47497

Citations are publications that use Tocris products.

Currently there are no citations for (±)-CP 47497.

Reviews for (±)-CP 47497

There are currently no reviews for this product. Be the first to review (±)-CP 47497 and earn rewards!

Have you used (±)-CP 47497?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


GPCR Product Listing

A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:

  • Rhodopsin-like Receptors
  • Glutamate Receptors
  • Frizzled Receptors
  • GPCR Signaling

Neurodegeneration Product Guide

A collection of over 275 products for neurodegeneration research, the guide includes research tools for the study of:

  • Alzheimer's disease
  • Parkinson's disease
  • Huntington's disease

Pain Research Product Guide

A collection of over 250 products for pain research, the guide includes research tools for the study of:

  • Nociception
  • Ion Channels
  • G-Protein-Coupled Receptors
  • Intracellular Signaling
Cannabinoid Receptor Ligands

Cannabinoid Receptor Ligands Scientific Review

Written by Roger Pertwee, this review discusses compounds which affect the activity of the endocannabinoid system, focusing particularly on ligands that are most widely used as experimental tools and denotes compounds available from Tocris.


Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.


Schizophrenia Poster

Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.